News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
High peripheral T cell diversity associated with lower risk of toxicity to dual ICI Therapy – JITC
faculty.mdanderson.org
Jan 3, 2025, 15:57

High peripheral T cell diversity associated with lower risk of toxicity to dual ICI Therapy – JITC

Journal for ImmunoTherapy of Cancer shared a post on X:

“New JITC article: High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC.”

High peripheral T cell diversity associated with lower risk of toxicity to dual ICI Therapy - JITC

High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC

Authors: Mehmet Altan et al.

T cell diversity

cancer Journal for ImmunoTherapy of Cancer (JITC) Mehmet Altan NSCLC OncoDaily Oncology
Special Coverage
Blog
Mar 17, 2025, 17:27
Lisa Lacasse: Raul Grijalva - a longtime champion of cancer-fighting policies
Blog
Mar 17, 2025, 17:23
Narjust Florez: Holding the higher number of pCR cases with Dr. Ugalde
Blog
Mar 17, 2025, 17:18
Nicole Stout: Great collaboration, hard work, and fun in Symptom Science and Palliative Care
Blog
Mar 17, 2025, 17:12
Melvin Chua: The beauty of academic medicine in global oncology collaboration
Blog
Mar 17, 2025, 17:04
IACH webinar - Management of High-Risk MDS: Where Do We Stand?
Blog
Mar 17, 2025, 16:53
Katy Beckermann: Excited to see the impact of a new care coordinator role for bladder cancer
Blog
Mar 17, 2025, 16:44
Eric Singhi: Thankful to Howard Jack West for believing, mentoring, and championing my passion
Insight
Mar 17, 2025, 16:30
Yelak Biru: Ongoing development of novel drugs and innovative combinations is key to pursuing a cure
Opinion
Mar 17, 2025, 16:23
David Gandara: Interesting read on cancer drug development strategies - "Mobo"
Career
Mar 17, 2025, 16:15
John-William Sidhom: Honored to receive the AACR Scholar-In-Training Award
Blog
Mar 17, 2025, 15:58
Howard Jack West: Biomarkers 101 talk for the GRACE forum on Targeted Therapies in lung cancer
Insight
Mar 17, 2025, 15:47
Highlights from SBGCC2025